Mucosal adjuvant activity of cholera toxin requires Th17 cells and protects against inhalation anthrax

SK Datta, M Sabet, KPL Nguyen… - Proceedings of the …, 2010 - National Acad Sciences
SK Datta, M Sabet, KPL Nguyen, PA Valdez, JM Gonzalez-Navajas, S Islam, I Mihajlov…
Proceedings of the National Academy of Sciences, 2010National Acad Sciences
Cholera toxin (CT) elicits a mucosal immune response in mice when used as a vaccine
adjuvant. The mechanisms by which CT exerts its adjuvant effects are incompletely
understood. We show that protection against inhalation anthrax by an irradiated spore
vaccine depends on CT-mediated induction of IL-17-producing CD4 Th17 cells.
Furthermore, IL-17 is involved in the induction of serum and mucosal antibody responses by
CT. Th17 cells induced by CT have a unique cytokine profile compared with those induced …
Cholera toxin (CT) elicits a mucosal immune response in mice when used as a vaccine adjuvant. The mechanisms by which CT exerts its adjuvant effects are incompletely understood. We show that protection against inhalation anthrax by an irradiated spore vaccine depends on CT-mediated induction of IL-17-producing CD4 Th17 cells. Furthermore, IL-17 is involved in the induction of serum and mucosal antibody responses by CT. Th17 cells induced by CT have a unique cytokine profile compared with those induced by IL-6 and TGF-β, and their induction by CT requires cAMP-dependent secretion of IL-1β and β-calcitonin gene-related peptide by dendritic cells. These findings demonstrate that Th17 cells mediate mucosal adjuvant effects of CT and identify previously unexplored pathways involved in Th17 induction that could be targeted for development of unique mucosal adjuvants.
National Acad Sciences